"Our vision is to be the unmatched leader in improving healthcare and reducing the barriers to health care for people in the communities we serve. We can serve all clients' general medical needs and accept new clients for primary care, specialty care for infectious diseases, or both. Rosedale makes it a priority to treat the entire patient, not just the symptoms or disease. We offer the highest and most innovative treatment plans for HIV/AIDS and aim to reduce your barriers to better health. An on-site Walgreen’s pharmacy, on-site laboratory, access to national and international research studies, mental health counseling, nutrition counseling, and patient advocates all make Rosedale the clear choice to be your partner in health."

During the past decade, Rosedale Infectious Diseases conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 14 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rosedale Infectious Diseases" #1 sponsor was "Gilead Sciences" with 17 trials, followed by "ViiV Healthcare" with 2 trials sponsored, "Pacgen Biopharmaceuticals Corporation" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Tobira Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rosedale Infectious Diseases" #1 collaborator was "Pfizer" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rosedale Infectious Diseases" are "HIV-1 Infection" (8 trials), "HIV Infections" (7 trials), "HIV" (6 trials), "HIV-1-infection" (2 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Rosedale Infectious Diseases" in a lesser frequency.

Most popular intervention types in "Rosedale Infectious Diseases" are "Drug" (22 trials). Other intervention types were less common.

The name of intervention was led by "ATV" (4 trials), "B/F/TAF" (4 trials), "FTC/TDF" (4 trials), "RTV" (4 trials) and "COBI" (3 trials). Other intervention names were less common.

The vast majority of trials in "Rosedale Infectious Diseases" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Rosedale Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Rosedale Infectious Diseases, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rosedale Infectious Diseases, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".